Role of Defective Oct-2 and OCA-B Expression in Immunoglobulin Production and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation in Primary Effusion Lymphoma
暂无分享,去创建一个
E. Cesarman | R. Sun | H. Deng | D. Knowles | A. Chadburn | E. Hyjek | S. Keller | I. Guasparri | Daniel L Di Bartolo
[1] J. Arapović,et al. The NK Cell Response to Mouse Cytomegalovirus Infection Affects the Level and Kinetics of the Early CD8+ T-Cell Response , 2011, Journal of Virology.
[2] Yan Wang,et al. Essential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA. , 2007, Virology.
[3] Sanjay Tyagi,et al. Kaposi's Sarcoma-Associated Herpesvirus Lytic Switch Protein Stimulates DNA Binding of RBP-Jk/CSL To Activate the Notch Pathway , 2006, Journal of Virology.
[4] D. Aucoin,et al. A Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 ORF50 Deletion Mutant Is Defective for Reactivation of Latent Virus and DNA Replication , 2005, Journal of Virology.
[5] H. Stein,et al. Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. , 2004, Blood.
[6] E. Cesarman,et al. KSHV-Positive Solid Lymphomas Represent an Extra-Cavitary Variant of Primary Effusion Lymphoma , 2004, The American journal of surgical pathology.
[7] L. Eckhardt,et al. Critical Role for the Oct-2/OCA-B Partnership in Ig-Secreting Cells1 , 2003, The Journal of Immunology.
[8] Frederick Y. Wu,et al. CCAAT/Enhancer-Binding Protein- (cid:2) Is Induced during the Early Stages of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Lytic Cycle Reactivation and Together with the KSHV Replication and Transcription Activator (RTA) Cooperatively Stimulates the Viral RTA, MTA, and PAN Promoters , 2003 .
[9] Paul Kellam,et al. Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Dalla‐Favera,et al. Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. , 2003, Blood.
[11] Sonia Sharma,et al. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines , 2003, Oncogene.
[12] Frederick Y. Wu,et al. Role of CCAAT/Enhancer-Binding Protein Alpha (C/EBPα) in Activation of the Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Lytic-Cycle Replication-Associated Protein (RAP) Promoter in Cooperation with the KSHV Replication and Transcription Activator (RTA) and RAP , 2003, Journal of Virology.
[13] Jiguo Chen,et al. Octamer-Binding Sequence Is a Key Element for the Autoregulation of Kaposi's Sarcoma-Associated Herpesvirus ORF50/Lyta Gene Expression , 2001, Journal of Virology.
[14] G. Lenz,et al. Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells. , 2001, Blood.
[15] V. Diehl,et al. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. , 2001, Cancer research.
[16] R. Sun,et al. Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. , 2000, The Journal of general virology.
[17] E. Cesarman,et al. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. , 2000, Blood.
[18] Sarah Nikiforow,et al. Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50/Rta Protein Activates the Entire Viral Lytic Cycle in the HH-B2 Primary Effusion Lymphoma Cell Line , 2000, Journal of Virology.
[19] R. Roeder,et al. Role of OCA-B in 3′-IgH Enhancer Function1 , 2000, The Journal of Immunology.
[20] A. Polack,et al. Inducible loss of NF-kappaB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. , 2000, Blood.
[21] D. Ganem,et al. Transcriptional Activation by the Product of Open Reading Frame 50 of Kaposi’s Sarcoma-Associated Herpesvirus Is Required for Lytic Viral Reactivation in B Cells , 1999, Journal of Virology.
[22] G. Gaidano,et al. Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas , 1999, Leukemia.
[23] G. Gaidano,et al. Genetic characterization of HHV‐8/KSHV–positive primary effusion lymphoma reveals frequent mutations of BCL6: Implications for disease pathogenesis and histogenesis , 1999, Genes, chromosomes & cancer.
[24] D. Ganem,et al. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. , 1998, Virology.
[25] E. Cesarman,et al. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation. , 1998, The American journal of pathology.
[26] R. Sun,et al. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[27] W. Herr,et al. OCA-B Is a Functional Analog of VP16 but Targets a Separate Surface of the Oct-1 POU Domain , 1998, Molecular and Cellular Biology.
[28] G. Gaidano,et al. Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. , 1997, Blood.
[29] D. Karcher,et al. Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm. , 1997, Human pathology.
[30] R. Sun,et al. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells , 1997, Journal of virology.
[31] G. Gaidano,et al. Kaposi's sarcoma‐associated herpesvirus DNA sequences in AIDS‐related and AIDS‐unrelated lymphomatous effusions , 1996, British journal of haematology.
[32] E. Cesarman,et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. , 1996, Blood.
[33] L. Picker,et al. Primary body cavity-based AIDS-related lymphomas. , 1996, American journal of clinical pathology.
[34] F. Sigaux,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.
[35] R. Roeder,et al. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B , 1995, Molecular and cellular biology.
[36] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.
[37] J. Newell,et al. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins , 1995, Cell.
[38] C. Hovens,et al. A B-cell coactivator of octamer-binding transcription factors , 1995, Nature.
[39] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[40] L. Madisen,et al. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. , 1994, Genes & development.
[41] D. Baltimore,et al. The immunoglobulin heavy chain locus contains another B-cell-specific 3' enhancer close to the alpha constant region , 1993, Molecular and cellular biology.
[42] R. Hipskind,et al. Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system. , 1993, The Journal of biological chemistry.
[43] A. Morley,et al. Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms. , 1992, Journal of clinical pathology.
[44] D. Latchman,et al. The octamer-binding protein Oct-2 represses HSV immediate-early genes in cell lines derived from latently infectable sensory neurons , 1991, Neuron.
[45] T. Jenuwein,et al. Complex pattern of immunoglobulin mu gene expression in normal and transgenic mice: nonoverlapping regulatory sequences govern distinct tissue specificities. , 1991, Genes & development.
[46] M. Neuberger,et al. The mouse IgH 3′‐enhancer , 1991, European journal of immunology.
[47] L. Eckhardt,et al. An enhancer at the 3' end of the mouse immunoglobulin heavy chain locus. , 1991, Nucleic acids research.
[48] A. Morley,et al. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. , 1990, Journal of clinical pathology.
[49] J. Said,et al. Diagnosis of malignant lymphoma in effusions from patients with AIDS by gene rearrangement. , 1990, American journal of clinical pathology.
[50] M. Neuberger,et al. A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus , 1990, Nature.
[51] W. Herr,et al. Differential transcriptional activation by Oct-1 and Oct-2: Interdependent activation domains induce Oct-2 phosphorylation , 1990, Cell.
[52] G. Inghirami,et al. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. , 1989, Blood.
[53] W. Schaffner,et al. A cloned octamer transcription factor stimulates transcription from lymphoid–specific promoters in non–B cells , 1988, Nature.
[54] R. Roeder,et al. A human lymphoid- specific transcription factor that activates immunoglobulin genes is a homoeobox protein , 1988, Nature.
[55] P. Sharp,et al. The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains. , 1988, Genes & development.
[56] P. O’Hare,et al. Direct combinatorial interaction between a herpes simplex virus regulatory protein and a cellular octamer‐binding factor mediates specific induction of virus immediate‐early gene expression. , 1988, The EMBO journal.
[57] W. Herr,et al. The ubiquitous octamer-binding protein Oct-1 contains a POU domain with a homeo box subdomain. , 1988, Genes & development.
[58] M. Frame,et al. A complex formed between cell components and an HSV structural polypeptide binds to a viral immediate early gene regulatory DNA sequence , 1988, Cell.
[59] L. Staudt,et al. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity , 1987, Nature.
[60] M. Dreyfus,et al. The conserved decanucleotide from the immunoglobulin heavy chain promoter induces a very high transcriptional activity in B‐cells when introduced into an heterologous promoter. , 1987, The EMBO journal.
[61] W. Schaffner,et al. Cell type‐specificity elements of the immunoglobulin heavy chain gene enhancer. , 1987, The EMBO journal.
[62] J. Mizushima-Sugano,et al. Cell-type-specific transcription of an immunoglobulin kappa light chain gene in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[63] P. Pellett,et al. Nucleotide sequence and predicted amino acid sequence of a protein encoded in a small herpes simplex virus DNA fragment capable of trans-inducing alpha genes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[64] M. Neuberger,et al. Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence , 1985, Cell.
[65] J. Palfreyman,et al. Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription. , 1984, Journal of molecular biology.
[66] D. Baltimore,et al. Two regulatory elements for immunoglobulin kappa light chain gene expression. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[67] W. Murphy,et al. Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[68] H. Zachau,et al. Correct transcription of an immunoglobulin κ gene requires an upstream fragment containing conserved sequence elements , 1984, Nature.
[69] S. Tonegawa,et al. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene , 1983, Cell.
[70] J. Banerji,et al. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes , 1983, Cell.
[71] B. Roizman,et al. Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha genes , 1983, Journal of virology.
[72] S. Mackem,et al. Regulation of α genes of herpes simplex virus: Expression of chimeric genes produced by fusion of thymidine kinase with α gene promoters , 1981, Cell.
[73] S. Rivest,et al. Cloning of murine TReP-132, a novel transcription factor expressed in brain regions involved in behavioral and psychiatric disorders , 2003, Molecular Psychiatry.
[74] M. Sigvardsson,et al. Transcriptional regulation in B cell differentiation. , 1999, Critical reviews in immunology.
[75] K. Calame,et al. Transcriptional regulation during B cell development. , 1998, Annual review of immunology.
[76] M. Ladanyi,et al. Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular study. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[77] Harinder Singh,et al. Genetic analysis of transcription factors implicated in B lymphocyte development , 1994, Immunologic research.
[78] W. Herr,et al. Differential positive control by Oct-1 and Oct-2: activation of a transcriptionally silent motif through Oct-1 and VP16 corecruitment. , 1993, Genes & development.
[79] S. Mackem,et al. Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters. , 1981, Cell.